Anna-Liisa Parts is Co-Founder and COO of Menken Trials, where she develops eTMF, eISF, and monitoring tools designed to keep clinical studies inspection-ready. With a background as a CRA and Clinical Lead at IQVIA, she brings deep operational experience in global study oversight, site management, and quality control. Anna-Liisa combines front-line clinical trial expertise with technology innovation to simplify inspection readiness and strengthen oversight in modern clinical research.
